The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 13,857 | 463,125 | SH | SOLE | 463,125 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 39,394 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
| ALECTOR INC | COM | 014442107 | 18,540 | 1,076,039 | SH | SOLE | 1,076,039 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 59,313 | 515,000 | SH | SOLE | 515,000 | 0 | 0 | ||
| BIOLIFE SOLUTIONS INC | COM NEW | 09062W204 | 39,941 | 2,468,571 | SH | SOLE | 2,468,571 | 0 | 0 | ||
| BLUEBIRD BIO INC | COM | 09609G100 | 85,118 | 970,000 | SH | SOLE | 970,000 | 0 | 0 | ||
| BRISTOL MYERS SQUIBB CO | RIGHT 99/99/9999 | 110122157 | 4,515 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 51,462 | 860,000 | SH | SOLE | 860,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 75,303 | 940,000 | SH | SOLE | 940,000 | 0 | 0 | ||
| CAREDX INC | COM | 14167L103 | 25,884 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 81,130 | 5,073,780 | SH | SOLE | 5,073,780 | 0 | 0 | ||
| CONSTELLATION PHARMCETICLS I | COM | 210373106 | 57,132 | 1,212,734 | SH | SOLE | 1,212,734 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 15,871 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
| DENALI THERAPEUTICS INC | COM | 24823R105 | 21,775 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 49,904 | 2,550,000 | SH | SOLE | 2,550,000 | 0 | 0 | ||
| FULCRUM THERAPEUTICS INC | +COM | 359616109 | 20,622 | 1,239,285 | SH | SOLE | 1,239,285 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 23,847 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 12,996 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 16,186 | 3,365,000 | SH | SOLE | 3,365,000 | 0 | 0 | ||
| GRITSTONE ONCOLOGY INC | COM | 39868T105 | 19,375 | 2,160,000 | SH | SOLE | 2,160,000 | 0 | 0 | ||
| ILLUMINA INC | COM | 452327109 | 19,904 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
| MAGENTA THERAPEUTICS INC | COM | 55910K108 | 46,968 | 3,098,121 | SH | SOLE | 3,098,121 | 0 | 0 | ||
| MYOKARDIA INC | COM | 62857M105 | 73,249 | 1,005,000 | SH | SOLE | 1,005,000 | 0 | 0 | ||
| INVITAE CORP | COM | 46185L103 | 58,687 | 3,638,388 | SH | SOLE | 3,638,388 | 0 | 0 | ||
| ORCHARD THERAPEUTICS PLC | ADS | 68570P101 | 11,275 | 820,000 | SH | SOLE | 820,000 | 0 | 0 | ||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 16,604 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
| SANGAMO THERAPEUTICS INC | COM | 800677106 | 12,178 | 1,455,000 | SH | SOLE | 1,455,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 86,457 | 670,000 | SH | SOLE | 670,000 | 0 | 0 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 3,682 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| TURNING POINT THERAPEUTICS I | COM | 90041T108 | 4,672 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| TWIST BIOSCIENCE CORP | COM | 90184D100 | 6,300 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | 15,276 | 1,095,075 | SH | SOLE | 1,095,075 | 0 | 0 | ||